Keyphrases
Sudden Death
100%
Hypertrophic Cardiomyopathy
100%
Amiodarone
100%
Ventricular Tachycardia
62%
Left Ventricular Function
25%
Survival Rate
25%
Treatment Initiation
12%
Empirical Therapy
12%
Drug Therapy
12%
Functional Improvement
12%
Ambulatory Monitoring
12%
Treadmill Exercise
12%
Symptomatic Patients
12%
Calcium Channel Blockers
12%
Antiarrhythmic Drugs
12%
Left Ventricular Filling
12%
Loading Dose
12%
Malignant Arrhythmia
12%
Exercise Duration
12%
2-year Survival
12%
1-year Survival
12%
New York Heart Association Functional Class
12%
Maintenance Dose
12%
Filling Ratio
12%
Holter Monitoring
12%
Radionuclide Angiography
12%
Diastolic Filling
12%
Calcium Antagonists
12%
Conduction Abnormalities
12%
Peak Filling Rate
12%
Class Status
12%
Conventional Drugs
12%
Medicine and Dentistry
Sudden Death
100%
Hypertrophic Cardiomyopathy
100%
Amiodarone
100%
Ventricular Tachycardia
62%
Survival Rate
25%
Cardiac Dysrhythmia
12%
New York Heart Association Class
12%
Treadmill Exercise
12%
Drug Therapy
12%
Maintenance Drug Dose
12%
Antiarrhythmic Agent
12%
Loading Drug Dose
12%
Radionuclide Ventriculography
12%
Holter Monitoring
12%
Ambulatory Monitoring
12%
Calcium Channel Blocking Agent
12%
Heart Left Ventricle Filling
12%
Calcium Antagonist
12%
Nursing and Health Professions
Sudden Death
100%
Hypertrophic Cardiomyopathy
100%
Amiodarone
100%
Heart Ventricle Tachycardia
62%
Survival Rate
25%
Heart Arrhythmia
12%
Drug Therapy
12%
Treadmill Exercise
12%
New York Heart Association Class
12%
Calcium Channel Blocking Agent
12%
Maintenance Drug Dose
12%
Holter Monitoring
12%
Calcium Antagonist
12%
Loading Drug Dose
12%
Ambulatory Monitoring
12%
Antiarrhythmic Agent
12%
Radionuclide Ventriculography
12%
Pharmacology, Toxicology and Pharmaceutical Science
Sudden Death
100%
Hypertrophic Cardiomyopathy
100%
Amiodarone
100%
Heart Ventricle Tachycardia
62%
Survival Rate
25%
Maintenance Dose
12%
Radioisotope
12%
Pharmacotherapy
12%
Heart Arrhythmia
12%
Calcium Antagonist
12%
Antiarrhythmic Agent
12%